Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXHL1100039	GW685698/GW642444	fluticasone furoate;vilanterol	Active ingredient	Chemical Drugs	Import Drug Application	2011-02-22	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2012-08-06	view
JXHL1000158	GW685698/GW642444	fluticasone furoate;vilanterol	Active ingredient	Chemical Drugs	Import Drug Application	2010-05-31	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2011-01-27	view
JXHL1000159	GW685698/GW642444	fluticasone furoate;vilanterol	Active ingredient	Chemical Drugs	Import Drug Application	2010-05-21	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2011-01-27	view
JXHL0900439	GW685698/GW642444	fluticasone furoate;vilanterol	Active ingredient	Chemical Drugs	Import Drug Application	2010-01-05	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2010-12-30	view
JXHL0900438	GW685698/GW642444	fluticasone furoate;vilanterol	Active ingredient	Chemical Drugs	Import Drug Application	2010-01-05	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2010-12-30	view
JXHL0900440	GW685698/GW642444	fluticasone furoate;vilanterol	Active ingredient	Chemical Drugs	Import Drug Application	2010-01-05	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2010-12-30	view